Coca-Cola (NYSE:KO) is ready for a new Life. After successful tests in Argentina and Chile, Coca-Cola's stevia-and-sugar-sweetened soda, Coke Life, will be rolled out in the U.K. this year.

The soda industry is dragging because of consumers wanting healthier beverages, whether it's less sugar overall or something other than the now controversial artificial sweeteners found in diet sodas. Coke hopes Life can reanimate some of its lagging sales by offering something a little more natural and healthy compared to its flagship products, Coke and Diet Coke.

In this episode of The Motley Fool's Where the Money Is, consumer-goods editor Mark Reeth has CG analyst Sean O'Reilly discuss whether Coke's new beverage will pump life into soda sales.


 

Mark Reeth has no position in any stocks mentioned. Sean O'Reilly has no position in any stocks mentioned. The Motley Fool recommends Coca-Cola. The Motley Fool has the following options: long January 2016 $37 calls on Coca-Cola and short January 2016 $37 puts on Coca-Cola. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.